Press Release: Zyngenia : Market Report, "Zyngenia, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile", published

(PR-inside.com) Zyngenia, Inc. (Zyngenia) is a biopharmaceutical company. The company develops drugs for cancer, inflammation and autoimmune disorders. Its technology platform includes Zybody. Zyngenia's Zybody therapeutics are the single-protein combination therapeutics, which are designed to create traditional attributes of monoclonal antibodies ,such as stability, ease of production, half-life, and effector function into a single antibody-like protein that interacts with multiple targets. The company's product pipeline includes TRI-SPECIFIC anti-her1, BI-SPECIFIC anti-her2, BI-SPECIFIC anti-tnfa and BI-SPECIFIC trail receptor-2. It has partnership with other biopharmaceutical companies. Zyngenia is headquartered in Gaithersburg, Maryland, the US. Full Report Details at - http://www.fastmr.com/prod/993298_zyngenia_pharmaceuticals.aspx?afid=701 Zyngenia, Inc. - Pharmaceuticals & Healthcare ..